|Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant|
J Lopez Bernal, N Andrews, C Gower, E Gallagher, R Simmons, ...
New England Journal of Medicine 385 (7), 585-594, 2021
|Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant|
N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard, E Gallagher, ...
New England Journal of Medicine 386 (16), 1532-1546, 2022
|Global epidemiology of meningococcal disease|
LH Harrison, CL Trotter, ME Ramsay
Vaccine 27, B51-B63, 2009
|Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity|
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, ┴ O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
|Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negativeá…|
JL Bernal, N Andrews, C Gower, C Robertson, J Stowe, E Tessier, ...
bmj 373, 2021
|Effectiveness of maternal pertussis vaccination in England: an observational study|
G Amirthalingam, N Andrews, H Campbell, S Ribeiro, E Kara, K Donegan, ...
The Lancet 384 (9953), 1521-1528, 2014
|Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction|
CL Trotter, NJ Andrews, EB Kaczmarski, E Miller, ME Ramsay
The Lancet 364 (9431), 365-367, 2004
|COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study|
VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ...
The Lancet 397 (10286), 1725-1735, 2021
|Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story|
E Miller, D Salisbury, M Ramsay
Vaccine 20, S58-S67, 2001
|Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study|
S de Lusignan, J Dorward, A Correa, N Jones, O Akinyemi, ...
The Lancet Infectious Diseases 20 (9), 1034-1042, 2020
|Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study|
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
|SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)|
VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ...
The Lancet 397 (10283), 1459-1469, 2021
|Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis|
ME Ramsay, NJ Andrews, CL Trotter, EB Kaczmarski, E Miller
Bmj 326 (7385), 365-366, 2003
|Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review|
KF Brown, JS Kroll, MJ Hudson, M Ramsay, J Green, SJ Long, CA Vincent, ...
Vaccine 28 (26), 4235-4248, 2010
|Immunisation against infectious diseases|
D Salisbury, M Ramsay, K Noakes
The Stationery Office, 2006
|Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentreá…|
APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ...
The Lancet 398 (10318), 2258-2276, 2021
|Global epidemiology of invasive meningococcal disease|
RZ Jafri, A Ali, NE Messonnier, C Tevi-Benissan, D Durrheim, J Eskola, ...
Population health metrics 11, 1-9, 2013
|Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England|
ME Ramsay, N Andrews, EB Kaczmarski, E Miller
The lancet 357 (9251), 195-196, 2001
|Measles outbreaks in a population with declining vaccine uptake|
VAA Jansen, N Stollenwerk, HJ Jensen, ME Ramsay, WJ Edmunds, ...
Science 301 (5634), 804-804, 2003
|Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study|
SN Ladhani, S Collins, A Djennad, CL Sheppard, R Borrow, NK Fry, ...
The Lancet Infectious Diseases 18 (4), 441-451, 2018